Site: Lung
Inclusion Criteria:
- No Rare Cancer
- No Prior History of Any Cancer
- Whites and Blacks Only
- No Reported Cancers in Controls
- No Erroneous Reports of Cancer
- Has Any Serum Available
- Has .5ml Most Proximal Pre-DX Serum 2-7 Years Prior to DX
- Has Genetic Consent
- Has .4ug of DNA/Source (Eligible)
- Individually Matched at a 1-1 Ratio
- Limit to Matched Cases and Controls
- Limit to Desired Smoking Groups (Selected)
Matching Factors:
- Gender
- Race
- Study Year of Draw
- Time of Draw
- Days in Study
- Date of Birth +- 5 years
- Date of Draw +- 6 months
Match Ratio: 1 to 1
Match Technique: Individual matching only non-cases as controls.
Analytes:
- 25-Hydroxyvitamin D2
- 25-Hydroxyvitamin D3
- 3-hydroxyanthranilic acid
- 4-pyridoxic acid
- Alpha Tocopherol
- Anthranilic Acid
- Any Amino Acid
- Arginine R
- Asymmetric dimethylarginine
- Betaine
- C-Reactive Protein
- Choline
- Cobalamin
- Cotinine
- Creatinine
- Cystathionine
- D-Neopterin
- Dihydrokainic acid
- Dimethylglycine
- Gamma Tocopherol
- Glycine
- Homocysteine
- Kynurenine
- L-homoarginine
- Methionine
- Methionine sulfoxide
- Methylmalonic acid
- Nicotanic Acid
- Nicotinamide
- Plasma Total Cysteine
- Protein
- Pyridoxal 5'-Phosphate
- Riboflavin
- Sarcosine
- Serine
- Supplemental Folate
- Symmetric dimethylarginine
- Tryptophan
- Valine
- kynurenic acid
- pyridoxal
- quinolinic acid
Number of Cases: 450
Number of Controls: 450
